RAMSAY GÉNÉRALE DE SANTÉ
Paris, 8 October 2014
PRESS RELEASE
Calling of a combined shareholders' meeting on 18 November 2014
The board of directors of Générale de Santé, chaired by Mr Christopher Rex, met on 7 October 2014 as composed after the board meeting held following the acquisition of 83.43% of the share capital of the company by Ramsay Health Care (UK) Ltd. and Predica on 1st October 2014.
The agenda of this meeting notably included the contemplated amendments of the Articles of Association of the company proposed by the new shareholders and mentioned in their statements of intent. The board decided to convene a general meeting to approve such amendments. The main amendments to the Articles of Association will address the following:
- reducing the double voting rights' holding period from five to two years;
- increasing the term of office of directors from three years to four years;
- providing for a list of decisions requiring the prior approval of the majority of two-thirds of the directors who are present, deemed present or represented at the board of directors; and
- possibility for the shareholders to participate in the general meeting by way of videoconference, provided that the board of directors permits it.
The board will also propose to the shareholders' general meeting to increase the number of members making up the company's Board to eleven, as well as the appointment of four new directors.
Finally, the board agreed on the principle of a cash distribution by Générale de Santé to its shareholders consisting in an interim dividend in a maximum amount of 79,6 million and an exceptional distribution in an amount of 60,4 million that would be wholly financed by the utilization of the credit facilities procured on 1st October 2014 when Générale de Santé has been refinanced. Such exceptional distribution, which, like the interim dividend, should take place before the end of the year, will be submitted to the approval of the combined general meeting called on 18 November 2014.
About Générale de Santé:
Générale de Santé, listed on the Euronext Paris Eurolist (formerly known as the Premier Marché) since June 2001, is included in the Midcac Index. The leading private healthcare and services group, Générale de Santé has 19,000 employees, including 7,000 nurses and 4,000 care staff in 75 facilities and centers.
With almost 4,500 practitioners, it is the leading independent medical community in France. As a major player in hospital care, Générale de Santé covers the entire healthcare chain: medical, surgery and obstetrics, oncology, after-care and rehabilitation, and home medical services. Générale de Santé has developed a unique healthcare offering combining quality and safety of care, efficient organization, and a human touch. The Group offers comprehensive care with personalized support before, during, and after hospitalization, taking into account all aspects of the patient's needs; it also operates in the public health service and national healthcare network.
For more information, go to www.generale-de-sante.fr:
http://www.generale-de-sante.fr/hopital-prive-d-antony
ISIN and Euronext Paris code: FR0000044471
Website: http://www.generale-de-sante.fr:
http://www.generale-de-sante.fr/
| Investor/Analyst relations: Arnaud Jeudy Tel. + 33 (0)1 53 23 14 75 a.jeudy@gsante.fr | Media relations: Martine Esquirou Tel. +33 (0) 1 53 23 12 62 m.esquirou@gsante.fr |
http://hugin.info/143423/R/1861468/652740.pdf
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: GENERALE DE SANTE via Globenewswire
